Leveraging Genetically Engineered Mouse Models of Small Cell Lung Cancer for Advanced Therapeutic St
4 Visualizzazioni
• 07/08/23
0
0
Incorporare
administrator
Iscritti
Anna Farago, MD
We have developed a series of genetically engineered mouse models of SCLC, in which conditional deletion of the tumor suppressor genes p53 and Rb1 in pulmonary epithelial cells triggers initiation of tumors that mirror the histology
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti